Epilepsy with auditory features …

Eliane Kobayashi MD PhD

Epilepsy & Seizures

Updated 07.06.2022
Released 07.07.2004
Expires For CME 07.06.2025

Epilepsy with auditory features

Author: Eliane Kobayashi MD PhD

See Contributor Disclosures

Editor: Jerome Engel Jr MD PhD

Epilepsy with auditory features

In This Article

Quick Link

Introduction

Overview

In this article, the author reports on current extended knowledge on pathogenesis of RELN gene mutations, as well as understanding of thresholds of transsynaptic LGI1-ADAM22 protein complexes for disease symptomatology derived from recent animal studies. In addition, an update on drug-resistance presentation among families with lateral temporal lobe epilepsy, and response to surgical interventions is provided.

Key points

	• Familial lateral temporal lobe epilepsy is typically characterized by auditory auras, but other types of clinical manifestations can be present in affected individuals.
	• Approximately 50% of families have a genetic diagnosis clarified, of which mutations in the LGI1 gene or RELN gene are the most frequent. Other genes implicated with this syndrome include DEPDC5 and SCNA1 genes.
	• Drug-resistant seizures and neuroimaging abnormalities might be present in some affected individuals, described in association with RELN mutations.
	• Few cases in the literature report on surgical treatment of drug-resistant seizures, with good outcomes to date.

Historical note and terminology

Genetic factors in the causation of epilepsy have been recognized since the time of Hippocrates. However, until the second half of the 20th century, generalized epilepsies were thought to be genetic in origin, whereas focal epilepsies were largely attributed to environmental factors, such as birth injuries, infections, postnatal head trauma, and brain lesions such as tumors and vascular insults.

In a series of publications (05; 01; 02; 03) based on patients operated for focal epilepsy at the Montreal Neurological Hospital, Eva Andermann was able to demonstrate that genetic factors were important in patients with focal epilepsy, particularly temporal lobe epilepsy, and that both generalized and focal epilepsies fit a model of multifactorial inheritance (now termed complex inheritance), with interaction of 1 or more genes and environmental factors.

It was only in the 1990s that several autosomal dominant forms of focal epilepsy were described by the group of Berkovic and colleagues (12). These included: autosomal dominant nocturnal frontal lobe epilepsy, familial temporal lobe epilepsy, familial focal epilepsy with variable foci, and autosomal dominant rolandic epilepsy with speech dyspraxia.

Familial temporal lobe epilepsy was included in the proposals for classification of epileptic syndromes by the International League Against Epilepsy, supporting it as a well-defined syndrome (37; 36; 09).

The first description of familial lateral temporal lobe epilepsy was in 1995 by Ottman and colleagues, who reported an autosomal dominant focal epilepsy syndrome with auditory features (77). Thus, autosomal dominant partial epilepsy syndrome with auditory features was regarded as a familial form of temporal lobe epilepsy with seizures semiology pointing to a neocortical or lateral temporal generator.

After detailed descriptions of many families with temporal lobe epilepsy, it has been possible to define 2 groups of familial temporal lobe epilepsy based on clinical and molecular characteristics (96; 04): familial mesial temporal lobe epilepsy, with clinical features of mesial temporal onset and no clear-cut molecular definition to date (59; 56); and familial lateral temporal lobe epilepsy, first described in association with LGI1 gene mutations in chromosome 10q (77; 53; 75).

It is important to recognize that it is impossible to distinguish familial and nonfamilial temporal lobe epilepsy patients based solely on the clinical presentation, for both mesial and lateral forms. As the family history is not always accurately documented and because some family members are asymptomatic or only mildly affected, many so-called “sporadic” or “isolated” patients may actually have a familial epilepsy syndrome.

Clinical manifestations

Presentation and course

The identification of a positive family history of seizures in patients with lateral temporal lobe epilepsy is not sufficient for a diagnosis of familial lateral temporal lobe epilepsy. The best definition of familial lateral temporal lobe epilepsy is based on the familial recurrence of lateral temporal lobe epilepsy, defined by clinical-EEG criteria according to the International League Against Epilepsy recommendations, in the absence of any suggestion of other focal or generalized epilepsy syndromes in other affected family members (27). Thus, the observation of at least 2 lateral temporal lobe epilepsy patients in 1 family is necessary, but not sufficient for the definition of familial lateral temporal lobe epilepsy. The observation of an autosomal dominant inheritance pattern with incomplete penetrance implies the presence of asymptomatic carriers of the genetic abnormalities, who can transmit the disease to their offspring. Therefore, we should consider inclusion of families not only with affected first-degree relatives, but also with affected second- and third-degree relatives.

Age of onset is variable, usually in the second or third decades of life. Seizures are with a few exceptions described in the literature easily controlled with antiseizure drugs. Familial lateral temporal lobe epilepsy is an overall benign epilepsy syndrome characterized by but not limited to the occurrence of auditory auras (buzzing, roaring, radio- or motor-like sounds, distortions in sounds and words). Although other manifestations such as psychic, cephalic and other sensory and motor phenomena can occur, the auditory auras are a landmark for this syndrome (77; 102; 101). Sometimes ictal aphasia and visual misperceptions can occur, and in some families, focal to bilateral tonic-clonic seizures are frequent (83; 102; 101; 20; 48; 58; 73). Families with rather psychic symptoms or with visual ictal manifestations associated with LGI1 mutations have also been described (92; 32). A report from the Epi4K Consortium families highlighted that amongst kindreds with temporal lobe epilepsy, a small proportion of them presented affected individuals that could have either mesial or lateral seizure semiology (38). A family with a mother and her offspring with drug-resistant seizures with a combination of auditory symptoms and ictal fear of left temporal onset has been described (70).

The presence of family members with episodes of tonic-clonic seizures only with no witnessed onset (therefore, possibly generalized or focal to bilateral), or with febrile seizures alone does not exclude the diagnosis of familial lateral temporal lobe epilepsy as these do not fulfill criteria for other epilepsy syndromes. Families with individuals who have such clinical manifestations could also be considered to have familial lateral temporal lobe epilepsy as long as at least 2 affected individuals fulfill the clinical and EEG criteria for lateral temporal lobe epilepsy.

EEGs may show temporal epileptiform discharges, but are frequently normal. No clear-cut signs of hippocampal atrophy are seen in MRI studies but a range of anatomical variations have been described in rare cases. A lateral/neocortical temporal malformation pattern has been observed in 45% of affected individuals in 1 large Brazilian family with an LGI1 mutation, including 1 asymptomatic carrier (58). The left temporal lobes of these individuals seemed enlarged, and sometimes a lateral protrusion of the brain parenchyma could be identified, with an “encephalocele-like” appearance. In another study, anterior temporal lobe volumetry showed a significant global increase in volumes in only 2 individuals. Subtle abnormalities in the posterior aspect of the left middle temporal gyrus were identified in familial lateral temporal lobe epilepsy patients as compared to controls using voxel-based analysis of fractional anisotropy maps (95).

Functional neuroimaging has also been applied to investigate dysfunction in these patients. One patient with an RELN mutation with normal 3T MRI was shown to have altered functional connectivity in the left hemisphere (22). Two Italian patients (proband and mother) with a missense RELN variant [c.6631C>T (p.Arg2211Cys)] and refractory epilepsy had seizures with ictal onset over the left temporal region captured in video-EEG recording, as well as neuroimaging abnormalities. Structural and metabolic neuroimaging abnormalities were found: [18F]FDG-PET showed left temporal hypometabolism and 3T MRI revealed a mild left temporal hypotrophy, slight blurring of the white and grey matter in the left temporal lobe, and hyperintensity of the left hippocampus (70).

Prognosis and complications

Familial lateral temporal lobe epilepsy has overall a benign clinical course with few refractory patients reported to date (77; 83; 102; 101; 20; 73; 70; 100). Many patients may present only a few episodes and then have spontaneous remission.

One study reported on long-term follow-up in patients with epilepsy with auditory features, including 123 patients with a median follow-up of 11 years (14). Approximately 32% of these patients reported a family history of epilepsy; 15 of them (12.2%) belonged to 11 familial lateral temporal lobe epilepsy pedigrees. The authors analyzed patients who were in seizure remission for at least 5 years at last follow-up. Total remission after tapering off antiseizure drugs might lead to relapses, but particular to this cohort is the marked heterogeneity in terms of phenotype (45). Poor prognostic factors for seizure control were: age at onset younger than 10 years, auditory aura characterized by complex auditory hallucinations, and focal epileptiform abnormalities on scalp EEG.

Neurologic disabilities in the form of auditory and language processing dysfunction have also been documented in families with familial lateral temporal lobe epilepsy and LGI1 mutations (81; 78).

Biological basis

Etiology and pathogenesis

A molecular diagnosis can be determined in approximately 50% of families, in which identification of mutations in the LGI1 as well as RELN genes have most often been described. Other less frequently implicated genes have also been described but they account for a minority of families in whom a mutation has been identified.

The LGI1 gene is mutated in approximately 30% of families with familial lateral temporal lobe epilepsy (10; 79). A large Italian study identified LGI1 mutations in only 30% of kindreds (72). Although LGI1 mutations appear to be specific for this type of temporal lobe epilepsy, the identification of LGI1 mutations in only one half of families presenting the typical phenotype (10; 79) suggests genetic heterogeneity in the families. A linkage to chromosome 19q13.11-q13.31 has been found in a large Brazilian kindred presenting with auditory auras (15).

A comprehensive review on LGI1 mutations in lateral temporal lobe epilepsy can be found in a paper by Nobile and colleagues (76) and in a review on pathogenic mechanisms in LGI1 mutations (105). The LGI1 gene was cloned from a glioblastoma cell line, and although previous studies have suggested that LGI1 represents a tumor suppressor gene (26), a more recent study was unable to establish a correlation between the gene and malignant glioma suppression (47). LGI1 (also known as Epitempin) is a secreted neuronal protein characterized by a central leucine-rich repeat region (51), which is involved in regulation of cell growth, adhesion, and migration.

Our understanding on the role of LGI1 in the epileptogenic process has significantly advanced. Fukata and colleagues demonstrated that LGI1 binds to the postsynaptic membrane proteins A Disintegrin And Metalloprotease (ADAM) 22 and 23, thus, linking LGI1 with modulation of glutamate-AMPA synaptic transmission by regulating the surface expression of AMPA receptors (44). In addition, defective LGI1 could lead to presynaptic changes in inactivation kinetics of A-type potassium channels through an effect on voltage-gated potassium channel subunit (Kv1.1), thus, increasing excitability (88).

Two protein isoforms of LGI1 are differentially expressed in the human brain, with a much higher concentration in the temporal neocortex than in the hippocampus, which could explain the characteristic auditory auras in patients with LGI1 mutation (46). The association of lateral temporal malformation patterns in some families may be indicative of a probable role of LGI1 in the development of the temporal lobes (58; 95).

At least 44 different LGI1 mutations have been described today. Most LGI1 mutations in familial lateral temporal lobe epilepsy patients are associated with loss-of-function, with the LGI1 protein either not secreted, misfolded, or unstable (82; 90; 62; 65). Exceptions are the mutations described by Striano and colleagues and Di Bonaventura and colleagues, as they do not affect LGI1 protein secretion (35; 92). Striano and colleagues also reported that the mutation found in their family does not induce large structural rearrangements although could destabilize its interactions with target proteins. Investigating LGI1 mutations described in familial lateral temporal lobe epilepsy as well as epilepsy due to LGI1 autoantibodies, Dazzo and colleagued have validated and introduced the concept that LGI1 mutations can be secretion-defective or secretion-competent, the latter resulting in impaired interaction between secreted LGI1 with neuronal receptors ADAM22 and ADAM23 (29). For a review of the interactions between LGI1 and ADAM receptors please refer to Yamagata and Fukai (105).

Many different mutations have been described in different kindreds worldwide, all located in the coding region or exon splice sites (48; 53; 75; 42; 58; 73; 82; 10; 18; 50; 79; 81; 25; 76; 55; 35; 92; 32; 54; 64). Bovo and colleagues analyzed the promoter region of the LGI1 gene in sporadic and familial lateral temporal lobe epilepsy patients and found no mutations in the promoter sequence (19).

LGI1 mutations have been identified in about 2% of nonfamilial cases (76). No mutations in LGI2, LGI3, or LGI4 have been identified in 71 families with various types of temporal lobe epilepsy, including 4 with familial lateral temporal lobe epilepsy (10; 07). Finally, no mutations related to the ADAM22 gene (23; 33) or Kv1 channel genes (33) have been identified in kindreds with familial lateral temporal lobe epilepsy without LGI1 mutations.

LGI1 microdeletions have been identified in families that tested negative for exon sequencing, suggesting that copy number variation analysis could help further understand mutation negative patients or families (41; 40). This has not been confirmed in a series of 8 families, and 20 sporadic patients tested negative for known LGI1 mutations (68).

Anderson has proposed, based on evidence from in vitro studies in transgenic mice (107), that LGI1 modulates a mechanism that could lead to epileptogenesis via persistent immaturity of glutamatergic circuitries (06). Interestingly, LGI1 has been demonstrated as the autoantigen for antibodies found in patients with limbic encephalitis, which had been previously attributed to voltage-gated potassium channels (61). These 2 observations point to a role of LGI1 in the maturation of glutamatergic neurotransmission and also in the etiology of acquired epilepsies.

Further insights about the mechanisms underlying epileptogenicity derived from LGI1 mutations have been unraveled in vitro using hippocampal CA3 neurons (89). LGI1 deletion resulted in downregulation of axonal Kv1.1 and Kv1.2 channels, thus, impairing the capacity of axonal D-type current to limit glutamate release. This could be a potential mechanism through which LGI1 regulates intrinsic excitability of neurons and promotes development of epileptogenicity.

Yokoi and colleagues aimed to investigate mechanisms through which levels of transsynaptic LGI1-ADAM22 protein complexes are regulated and what level of function or impairment of LGI1-ADAM22 complexes is required for disease symptomatology to occur (106). Their study demonstrated, using ADAM22 and LGI1 hypomorphic mice, that levels at approximately 50% of LGI1 and approximately 10% of ADAM22 are sufficient to prevent lethal epilepsy. In addition, it showed evidence that quantitative dual phosphorylation of ADAM22 by protein kinase A (PKA) mediates high-affinity binding of ADAM22 to dimerized 14-3-3, “protecting” LGI1-ADAM22 from endocytosis-dependent degradation. It remains to be further evidenced whether these results support increasing levels of LGI1-ADAM22 complexes as potential pharmacological strategy for treatment for epilepsy, as suggested by the authors (106).

Heterozygous mutations in the gene encoding for the secreted protein reelin (RELN) on chromosome 7q have been found in 17% of kindreds that tested negative for LGI1 mutations, providing an interesting new venue for understanding the pathophysiology of this epilepsy syndrome (28; 74; 70). Homozygous RELN mutations cause lissencephaly with cerebellar hypoplasia, and as the authors found an inhibitory effect of mutations on protein secretion and co-localization of LGI1 and RELN in many rat brain regions, they bring to discussion the regulatory role these 2 proteins exert in brain development.

It is estimated that disease-causing heterozygous mutations in RELN gene are segregated in about 20% of families with familial lateral temporal lobe epilepsy (30). Pathogenic mutations, through impaired trafficking of mutant reelin along the secretory pathway as well as elimination through the autophagy pathway, result in abolished or significantly reduced reelin, which can be, nevertheless, partially rescued by small-molecule correctors.

Pippucci and colleagues used whole exome sequencing to investigate probands who tested negative for known LGI1 mutations and found CNTNAP2 intragenic deletion, 2 truncating mutations of DEPDC5 gene, and a missense SCN1A change (80). Interestingly, CNTNAP2 encodes Contactin-associated protein-like 2 (CASPR2), a cell adhesion protein of the neurexin family, which plays a role in the localization of the voltage-gated potassium channel complex composed of TAG-1, Kv1.1, and Kv1.2, with which LGI1 interacts. In contrast, DEPDC5 has been originally identified in familial focal epilepsy with variable foci and now in about 10% of focal epilepsies, including patients with an underlying malformation of cortical development. No DEPDC5 mutations were found in another cohort of familial lateral temporal lobe epilepsy patients who tested negative for LGI1 mutations (93).

However, in a subsequent study, Leonardi and colleagues screened 28 familial lateral temporal lobe epilepsy kindreds that had tested negative for LGI1 and RELN mutations and found no CNTNAP2 (contactin associated protein like 2) mutations with next-generation sequencing and copy number variation analyses (63).

Using whole exome sequencing combined with genome-wide single-nucleotide polymorphism-array linkage analysis, Dazzo and colleagues described 2 variants in the MICAL-1 (microtubule-associated monooxy-genase, calponin, and lim domain containing 1) gene in 2 different families with familial lateral temporal lobe epilepsy (31). MICAL-1 had been described as an F-actin-disassembly factor critical in actin reorganization, providing a molecular conduit for axon navigation (67). Dysregulation of the actin cytoskeleton dynamics remain as a possible mechanism for these pathogenic variants (31).

Finally, 2 possibly pathogenic missense variants in the SCN1A gene were identified in 3.8% of sporadic patients in a cohort of lateral temporal lobe epilepsy with no antecedent of febrile seizures (13). Patients within GEFS+ families could present with typical semiology with auditory features and carry SCN1A mutations.

In the most recent and large genetic study in lateral temporal lobe epilepsy including 112 unrelated cases (of whom 33 were familial patients), Bisulli and colleagues applied next-generation sequencing and confirmed an underlying genetic abnormality in 8% of individuals (16). Pathogenic or likely pathogenic variants were identified in LGI1 (2.7%), RELN (1.8%), SCN1A (2.7%), and DEPDC5 (0.9%). Amongst the familial cases in this cohort, the following was the proportion of variants found: LGI1 (3%), RELN (6.1%), SCN1A (3%), and DEPDC5 (3%).

Differential diagnosis

The 2 main differential diagnoses for familial lateral temporal lobe epilepsy are sporadic lateral temporal lobe epilepsy and familial mesial temporal lobe epilepsy, which can be clarified most of the time with a detailed history and seizure description. In addition, familial focal epilepsy with variable foci should be considered.

The presence of patients with lateral temporal lobe epilepsy but without a positive family history was highlighted by Bisulli and colleagues (17). The authors termed this syndrome idiopathic focal epilepsy with auditory features, and performed a clinical and genetic study in 53 sporadic cases. Mutations in LGI1 were excluded in all these patients with idiopathic partial epilepsy with auditory features although, except for the absence of family history, these patients had identical clinical manifestations to those seen in familial lateral temporal lobe epilepsy, including the always-good prognosis (17). After the first description of their large series, the same authors reported a de novo mutation in the LGI1 gene in 1 patient with sporadic lateral temporal lobe epilepsy (18). A de novo LGI1 mutation has also been reported in a patient with idiopathic epilepsy and telephone-induced seizures (71). However, other series of patients with sporadic lateral temporal lobe epilepsy found no LGI1 mutations (43; 19). Overall, approximately 2% of nonfamilial cases will show an LGI1 mutation (76).

To date, no families with familial mesial temporal lobe epilepsy have been found to have an LGI1 mutation, even in those families where 1 or more family members had auditory features alone or in association with mesial symptoms (84; 08; 10). This further supports the fact that familial lateral temporal lobe epilepsy and familial mesial temporal lobe epilepsy constitute separate genetic syndromes. The implication of LGI1 with seizures of mesial temporal origin rather than neocortical onset is, however, suggested by the study of Chabrol and colleagues using LGI1 knockout mice (24). Frequent spontaneous seizures originating from the hippocampus were seen in homozygous animals, and hippocampal pathology consistent with sclerosis was observed. In contrast, heterozygous animals showed only auditory stimuli-induced seizures.

Patients with temporal lobe epilepsy are found in other familial epilepsy syndromes. In familial epilepsy with variable foci, different family members may present with various forms of epilepsy, including temporal lobe epilepsy (57), but the focus remains the same in each affected individual. Most reported families mapped to chromosome 22q (87; 104; 103; 21; 11). Subsequently, mutations in the DEPDC5 gene encoding the poorly characterized DEP domain containing 5 protein were described not only in FFEVF families, but also in other familial focal epilepsies (52; 34; 69).

In generalized epilepsy with febrile seizure plus (GEFS+), related to mutations in genes SCN1A, SCN1B, SCN2A, and GABRG2 (99; 97; 98; 39; 66; 94; 49), patients may present heterogeneous epilepsy phenotypes. Febrile seizures are the most common phenotype, followed by febrile seizures plus (FS+), where individuals have seizures with fever that may persist beyond the age of 6 years and may be associated with afebrile generalized tonic-clonic seizures (85; 91). Less frequent phenotypes seen in generalized epilepsy with febrile seizure plus involve other generalized seizure types, including temporal lobe epilepsy (85; 91; 98; 86). Patients with focal seizures typical of lateral temporal lobe epilepsy have been described within the context of GEFS+ kindreds, without febrile seizures and bearing an SCN1A mutation (13; 16).

It is essential to evaluate the phenotype of all possibly affected individuals before classifying the family to have a specific familial syndrome. In addition, because phenotypes may vary, we can never be absolutely sure that an “isolated” or “sporadic” lateral temporal lobe epilepsy patient does not have familial lateral temporal lobe epilepsy. Molecular studies with testing for mutations of genes previously identified in these families, as well as other genes associated with related familial epilepsies can be helpful.

References

01: Andermann E. Multifactorial inheritance in the epilepsies. In: Canger R, Angeleri F, Penry JK, editors. Advances in epileptology. XII. Epilepsy International Symposium. New York: Raven Press, 1980:297-309.
02: Andermann E. Multifactorial inheritance of generalized and focal epilepsies. In: Anderson VE, editor. Genetic basis of the epilepsies. New York: Raven Press, 1982:355-74.
03: Andermann E. Genetic aspects of the epilepsies. In: Sakai T, Tsuboi T, editors. Genetic aspects of human behavior. Tokyo: Igaku-Shoin Medical Publishers, 1985:129-45.
04: Andermann F, Kobayashi E, Andermann E. Genetic focal epilepsies: state of the art and paths to the future. Epilepsia 2005;46(Suppl 10):61-7. PMID 16359475
05: Andermann E, Metrakos JD. EEG studies of relatives of probands with focal epilepsy who have been treated surgically. Epilepsia 1969;10(3):415. PMID 4979085
06: Anderson MP. Arrested glutamatergic synapse development in human partial epilepsy. Epilepsy Curr 2010;10(6):153-8. PMID 21157544
07: Ayerdi-Izquierdo A, Stavrides G, Selles-Martinez JJ, et al. Genetic analysis of the LGI/Epitempin gene family in sporadic and familial lateral temporal lobe epilepsy. Epilepsy Res 2006;70:118-26. PMID 16707245
08: Badhwar A, Racacho L, D’Agostino D, et al. Absence of LGI1 mutations in familial mesial temporal lobe epilepsy with or without auditory features and in sporadic TLE with auditory features. Neurology 2004;62(Suppl 5):A252. PMID 15079010
09: Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51(4):676-85. PMID 20196795
10: Berkovic SF, Izzillo P, McMahon JM, et al. LGI1 mutations in temporal lobe epilepsies. Neurology 2004a;62(7):1115-9. PMID 15079010
11: Berkovic SF, Serratosa JM, Phillips HA, et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 2004b;45(9):1054-60. PMID 15329069
12: Berkovic SF, Steinlein OK. Genetics of partial epilepsies. Adv Neurol 1999;79:375-81. PMID 10514827
13: Bisulli F, Licchetta L, Baldassari S, et al. SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus. Epileptic Disord 2019;21(2):185-91. PMID 30977726
14: Bisulli F, Menghi V, Vignatelli L, et al. Epilepsy with auditory features: long-term outcome and predictors of terminal remission. Epilepsia 2018;59(4):834-43. PMID 29464704
15: Bisulli F, Naldi I, Baldassari S, et al. Autosomal dominant partial epilepsy with auditory features: a new locus on chromosome 19q13.11-q13.31. Epilepsia 2014;55(6):841-8. PMID 24579982
16: Bisulli F, Rinaldi C, Pippucci T, et al. Epilepsy with auditory features: contribution of known genes in 112 patients. Seizure 2021;85:115-8.** PMID 33453592
17: Bisulli F, Tinuper P, Avoni P, et al. Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain 2004a;127(Pt 6):1343-52. PMID 15090473
18: Bisulli F, Tinuper P, Scudellaro E, et al. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol 2004b;56(3):455-6. PMID 15349881
19: Bovo G, Diani E, Bisulli F, et al. Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. Neurosci Lett 2008;436(1):23-6. PMID 18355961
20: Brodtkorb E, Gu W, Nakken KO, Fischer C, Steinlein OK. Familial temporal lobe epilepsy with aphasic seizures and linkage to chromosome 10q22-q24. Epilepsia 2002;43(3):228-35. PMID 11906506
21: Callenbach PM, van den Maagdenberg AM, Hottenga JJ, et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 2003;44(10):1298-305. PMID 14510823
22: Ceska K, Aulická Š, Horák O, et al. Autosomal dominant temporal lobe epilepsy associated with heterozygous reelin mutation: 3 T brain MRI study with advanced neuroimaging methods. Epilepsy Behav Case Rep 2018;11:39-42. PMID 30619712
23: Chabrol E, Gourfinkel-An I, Scheffer IE, et al. Absence of mutations in the LGI1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy. Epilepsy Res 2007a;76(1):41-8. PMID 17681454
24: Chabrol E, Navarro V, Provenzano G, et al. Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice. Brain 2010;133(9):2749-62. PMID 20659958
25: Chabrol E, Popescu C, Gourfinkel-An I, et al. Two novel epilepsy-linked mutations leading to a loss of function of LGI1. Arch Neurol 2007b;64(2):217-22. PMID 17296837
26: Chernova OB, Somerville RP, Cowell JK. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998;17(22):2873-81. PMID 9879993
27: Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4):389-99. PMID 2502382
28: Dazzo E, Fanciulli M, Serioli E, et al. Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet 2015b;96(6):992-1000. PMID 26046367
29: Dazzo E, Leonardi E, Belluzzi E, et al. Secretion-positive LGI1 mutations linked to lateral temporal epilepsy impair binding to ADAM22 and ADAM23 receptors. PLoS Genet 2016;12(10):e1006376. PMID 27760137
30: Dazzo E, Nobile C. Epilepsy-causing Reelin mutations result in impaired secretion and intracellular degradation of mutant proteins. Hum Mol Genet 2022;31(5):665-73. PMID 34508592
31: Dazzo E, Rehberg K, Michelucci R, et al. Mutations in MICAL-1cause autosomal-dominant lateral temporal epilepsy. Ann Neurol 2018;83(3):483-93. PMID 29394500
32: Dazzo E, Santulli L, Posar A, et al. Autosomal dominant lateral temporal epilepsy (ADLTE): novel structural and single-nucleotide LGI1 mutations in families with predominant visual auras. Epilepsy Res 2015a;110:132-8. PMID 25616465
33: Diani E, Di Bonaventura C, Mecarelli O, et al. Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res 2008;80(1):1-8. PMID 18440780
34: Dibbens LM, de Vries B, Donatello S, et al. Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nat Genet 2013;45(5):546-51. PMID 23542697
35: Di Bonaventura C, Operto FF, Busolin G, et al. Low penetrance and effect on protein secretion of LGI1 mutations causing autosomal dominant lateral temporal epilepsy. Epilepsia 2011;52(7):1258-64. PMID 21504429
36: Engel J Jr. Report of the ILAE classification core group. Epilepsia 2006;47(9):1558-68. PMID 16981873
37: Engel J Jr; International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology Epilepsia 2001;42(6):796-803. PMID 11422340
38: Epi4K Consortium. Phenotypic analysis of 303 multiplex families with common epilepsies. Brain 2017;140(8):2144-56. PMID 28899008
39: Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000;24(4):343-5. PMID 10742094
40: Fanciulli M, Pasini E, Malacrida S, et al. Copy number variations and susceptibility to lateral temporal epilepsy: a study of 21 pedigrees. Epilepsia 2014;55(10):1651-8. PMID 25243798
41: Fanciulli M, Santulli L, Errichiello L, et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology 2012;78(17):1299-303. PMID 22496201
42: Fertig E, Lincoln A, Martinuzzi A, Mattson RH, Hisama FM. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology 2003;60:1687-90. PMID 12771268
43: Flex E, Pizzuti A, Di Bonaventura C, et al. LGI1 gene mutation screening in sporadic partial epilepsy with auditory features. J Neurol 2005;252(1):62-6. PMID 15654555
44: Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006;313(5794):1744-5. PMID 16990550
45: Furia A, Licchetta L, Muccioli L, at al. Epilepsy with auditory features: from etiology to treatment. Front Neurol 2022;12:807939. PMID 35153984
46: Furlan S, Roncaroli F, Forner F, et al. The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain. J Neurochem 2006;98(3):985-91. PMID 16787412
47: Gu W, Brodtkorb E, Piepoli T, Finocchiaro G, Steinlein OK. LGI1: a gene involved in epileptogenesis and glioma progression. Neurogenetics 2005;6(2):59-66. PMID 15827762
48: Gu W, Brodtkorb E, Steinlein OK. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 2002;52(3):364-7. PMID 12205652
49: Harkin LA, Bowser DN, Dibbens LM, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002;70(2):530-6. PMID 11748509
50: Hedera P, Abou-Khalil B, Crunk AE, Taylor KA, Haines JL, Sutcliffe JS. Autosomal dominant lateral temporal epilepsy: two families with novel mutations in the LGI1 gene. Epilepsia 2004;45:218-22. PMID 15009222
51: Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998;17(1):1-19. PMID 9628249
52: Ishida S, Picard F, Rudolf G, et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013;45(5):552-5. PMID 23542701
53: Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal dominant partial epilepsy with auditory features. Nat Genet 2002;30(3):335-41. PMID 11810107
54: Kanwal S, Yoo DH, Tahir S, et al. A novel nonsense mutation in leucine-rich, glioma-inactivated-1 gene as the underlying cause of familial temporal lobe epilepsy. J Clin Neurol 2018;14(4):591-3. PMID 30284771
55: Kawamata J, Ikeda A, Fujita Y, et al. Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy: the first report from Asian families. Epilepsia 2010;51(4):690-3. PMID 19780791
56: Kobayashi E, Andermann F, Andermann E. Familial mesial temporal lobe epilepsy. In: Gilman S, editor. MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Accessed June 2009a.
57: Kobayashi E, Andermann F, Andermann E. Familial partial epilepsy with variable foci. In: Gilman S, editor. MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Accessed June 2009b.
58: Kobayashi E, Santos NF, Torres FR, et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol 2003;60(11):1546-51. PMID 14623726
59: Kobayashi E, Sousa SC, Lopes-Cendes I, et al. Seizure outcome and hippocampal atrophy in familial mesial temporal lobe epilepsy. Neurology 2001;56(2):166-72. PMID 11160950
60: Koizumi S, Kawai K, Asano S, Ueki K, Suzuki I, Saito N. Familial lateral temporal lobe epilepsy confirmed with intracranial electroencephalography and successfully treated by surgery. Neurol Med Chir (Tokyo) 2011;51(8):604-10. PMID 21869587
61: Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9(8):776-85. PMID 20580615
62: Lee MK, Kim SW, Lee JH, et al. A newly discovered LGI1 mutation in Korean family with autosomal dominant lateral temporal lobe epilepsy. Seizure 2014;23(1):69-73. PMID 24177143
63: Leonardi E, Dazzo E, Aspromonte MC, et al. CNTNAP2 mutations and autosomal dominant epilepsy with auditory features. Epilepsy Res 2018;139:51-3. PMID 29179159
64: Liu F, Du C, Tian X, et al. A novel LGI1 missense mutation causes dysfunction in cortical neuronal migration and seizures. Brain Res 2019;1721:146332. PMID 31301272
65: Liu J, Hu D, Zhang Z, Tang F, Yan Y, Ma Y. Autosomal dominant lateral temporal epilepsy in a family exhibiting a rare heterozygous mutation and deletion in the leucine-rich glioma inactivated 1 gene. Neurosci Lett 2022;782:136698. PMID 35643238
66: Lopes-Cendes I, Scheffer IE, Berkovic SF, Rousseau M, Andermann E, Rouleau GA. A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2. Am J Hum Genet 2000;66(2):698-701. PMID 10677328
67: Luo J, Xu Y, Zhu Q, et al. Expression pattern of Mical-1 in the temporal neocortex of patients with intractable temporal epilepsy and pilocarpine-induced rat model. Synapse 2011;65(11):1213-21. PMID 21638339
68: Manna I, Mumoli L, Labate A, et al. Autosomal dominant lateral temporal epilepsy (ADLTE): Absence of chromosomal rearrangements in LGI1 gene. Epilepsy Res 2014;108(3):597-9. PMID 24315022
69: Martin C, Meloche C, Rioux MF, et al. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin Genet 2014;86(6):570-4. PMID 24283814
70: Michelucci R, Dazzo E, Volpi L, et al. Autosomal dominant lateral temporal lobe epilepsy associated with a novel reelin mutation. Epileptic Disord 2020;22(4):443-8. PMID 32723706
71: Michelucci R, Mecarelli O, Bovo G, et al. A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures. Neurology 2007;68:2150-1. PMID 17562837
72: Michelucci R, Pasini E, Malacrida S, et al. Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations. Epilepsia 2013;54(7):1288-97. PMID 23621105
73: Michelucci R, Poza JJ, Sofia V, et al. Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia 2003; 44(10):1289-97. PMID 14510822
74: Michelucci R, Pulitano P, Di Bonaventura C, et al. The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations. Epilepsy Behav 2017;68:103-7.** PMID 28142128
75: Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S, et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal lobe epilepsy. Hum Mol Genet 2002;11(9):1119-28. PMID 11978770
76: Nobile C, Michelucci R, Andreazza S, Pasini E, Tosatto SC, Striano P. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 2009;30(4):530-6. PMID 19191227
77: Ottman R, Risch N, Hauser WA, et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat Genet 1995;10(1):56-60. PMID 7647791
78: Ottman R, Rosenberger L, Bagic A, et al. Altered language processing in autosomal dominant partial epilepsy with auditory features. Neurology 2008;71(24):1973-80. PMID 19064878
79: Ottman R, Winawer MR, Kalachikov S, et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004; 62(7):1120-6. PMID 15079011
80: Pippucci T, Licchetta L, Baldassari S, et al. Epilepsy with auditory features: a heterogeneous clinico-molecular disease. Neurol Genet 2015;1(1):e5. PMID 27066544
81: Pisano T, Marini C, Brovedani P, et al. Abnormal phonologic processing in familial lateral temporal lobe epilepsy due to a new LGI1 mutation. Epilepsia 2005;46:118-23. PMID 15660777
82: Pizzuti A, Flex E, Di Bonaventura C, et al. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol 2003;53:396-9. PMID 12601709
83: Poza JJ, Saenz A, Martinez-Gil A, et al. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol 1999;45(2):182-8. PMID 9989620
84: Santos NF, Sousa SC, Kobayashi E, et al. Clinical and genetic heterogeneity in familial temporal lobe epilepsy. Epilepsia 2002;43 Suppl 5:136. PMID 12121308
85: Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997;120 (Pt 3):479-90. PMID 9126059
86: Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007;130(Pt 1):100-9. PMID 17020904
87: Scheffer IE, Phillips HA, O'Brien CE, et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol 1998;44(6):890-9. PMID 9851433
88: Schulte U, Thumfart JO, Klöcker N, et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006;49(5):642-4. PMID 16504945
89: Seagar M, Russier M, Caillard O, et al. LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels. Proc Natl Acad Sci U S A 2017;114(29):7719-24.** PMID 28673977
90: Senechal KR, Thaller C, Noebels JL. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet 2005;14(12):1613-20. PMID 15857855
91: Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999;45(1):75-81. PMID 9894880
92: Striano P, Busolin G, Santulli L, et al. Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 2011;76(13):1173-6. PMID 21444903
93: Striano P, Serioli E, Santulli L, et al. DEPDC5 mutations are not a frequent cause of familial temporal lobe epilepsy. Epilepsia 2015;56(10):e168-71. PMID 26216793
94: Sugawara T, Tsurubuchi Y, Agarwala KL, et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 2001;98(11):6384-9. PMID 11371648
95: Tessa C, Michelucci R, Nobile C, et al. Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. Neurology 2007;69(12):1298-300. PMID 17875918
96: Vadlamudi L, Scheffer IE, Berkovic SF. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003;74(10):1359-61. PMID 14570824
97: Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001;68(4):859-65. PMID 11254444
98: Wallace RH, Scheffer IE, Parasivam G, et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 2002;58(9):1426-9. PMID 12011299
99: Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet 1998;19(4):366-70. PMID 9697698
100: Wei Z, Ye X, Wang C, et al. Case report: stereoelectroencephalography and stereoelectroencephalography-guided radiofrequency thermocoagulation in familial lateral temporal lobe epilepsy. Front Neurol 2022;13:864070. PMID 35444610
101: Winawer MR, Martinelli Boneschi F, Barker-Cummings C, et al. Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia 2002;43(1):60-7. PMID 11879388
102: Winawer MR, Ottman R, Hauser WA, Pedley TA. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 2000;54(11):2173-6. PMID 10851389
103: Xiong L. Identification, clinical characterization, and molecular genetic studies of familial partial epilepsy with variable foci. PhD thesis, McGill University, 2002.
104: Xiong L, Labuda M, Li DS, et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am J Hum Genet 1999;65(6):1698-710. PMID 10577924
105: Yamagata A, Fukai S. Insights into the mechanisms of epilepsy from structural biology of LGI1-ADAM22. Cell Mol Life Sci 2020;77(2):267-74.** PMID 31432233
106: Yokoi N, Fukata Y, Okatsu K, et al. 14-3-3 proteins stabilize LGI1-ADAM22 levels to regulate seizure thresholds in mice. Cell Rep 2021;37(11):110107. PMID 34910912
107: Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009;15(10):1208-14. PMID 19701204

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Eliane Kobayashi MD PhD

Dr. Kobayashi of McGill University received honorariums for advisory board membership from Palladin Laboratories and Jazz Pharmaceuticals.
See Profile

Editor

Jerome Engel Jr MD PhD

Dr. Engel of the David Geffen School of Medicine at the University of California, Los Angeles, has no relevant financial relationships to disclose.
See Profile

Former Authors

Eva Andermann MD PhD and Frederick Andermann MD

Patient Profile

Age range of presentation: 6 to 44 years
Sex preponderance: male=female
Heredity: Autosomal dominant
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none

ICD & OMIM codes

ICD-10: Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures: G40.1

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures: G40.2
OMIM: Contactin-associated protein-like 2; CNTNAP2: *604569

DEP domain-containing protein 5; DEPDC5: *614191

Lateral temporal lobe epilepsy, autosomal dominant: #600512

Leucine-rich glioma inactivated 1 gene: *604619

MICAL1: *607129

Microtubule-associated monooxygenase, calponin and lim domains-containing, 1; Reelin; RELN: *600514

Sodium voltage-gated channel, alpha subunit 1; SCN1A: *182389

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Epilepsy with auditory features

Differential Diagnosis

familial mesial temporal lobe epilepsy
familial focal epilepsy with variable foci
generalized epilepsy with febrile seizures plus
idiopathic partial epilepsy with auditory features
isolated lateral temporal lobe epilepsy
- nonfamilial temporal lobe epilepsy
- sporadic lateral temporal lobe epilepsy

Also Relevant

Epilepsy
Familial focal epilepsy with variable foci
Familial mesial temporal lobe epilepsy
Mesial temporal lobe epilepsy with hippocampal sclerosis
Neocortical temporal lobe seizures

Clinical Categories

Epilepsy & Seizures

Patient Handouts

Seizure first aid

Web References

Guidelines

Epilepsy with auditory features …

Epilepsy with auditory features

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Anti-LGI1 encephalitis

Self-limited (familial) neonatal epilepsy

Alcohol withdrawal seizures

Epileptic lesions due to malformation of cortical development

Epileptic spasms

Sleep and epilepsy

Neocortical temporal lobe seizures

Jacksonian seizures

Epilepsy with auditory features

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Anti-LGI1 encephalitis

Self-limited (familial) neonatal epilepsy

Alcohol withdrawal seizures

Epileptic lesions due to malformation of cortical development

Epileptic spasms

Sleep and epilepsy

Neocortical temporal lobe seizures

Jacksonian seizures

This is an article preview.
Start a Free Account
to access the full version.